Surveillance of Medication Use During Pregnancy in the Mini-Sentinel Program

Project Title Surveillance of Medication Use During Pregnancy in the Mini-Sentinel Program
Date
Tuesday, December 8, 2015
Location
Description

This article describes the capability of the Mini-Sentinel pilot to provide prevalence rates of medication use among pregnant women delivering a liveborn infant.

The cohorts of interest are women ages 10 to 54 delivering a liveborn infant, and age- and date-matched non-pregnant women.

Medical Product
angiotensin-converting enzyme (ACE) inhibitor
anticonvulsant
dabigatran
lisinopril
methotrexate
mycophenolate mofetil
paroxetine
ribavirin
selective serotonin reuptake inhibitor (SSRI)
simvastatin
sodium valproate
statin
valproic acid
warfarin
Time Period
2001-2012
Corresponding Author

S. Andrade, Meyers Primary Care Institute (Fallon Community Health Plan, Reliant Medical Group, and University of Massachusetts Medical School), 630 Plantation St., Worcester, MA, 01605, USA. Email: sandrade@meyersprimary.org

Authors

Susan Andrade ScD; Darren Toh ScD; Monika Houstoun PharmD, MPH; Katrina Mott MHS; Marilyn Pitts PharmD; Caren Kieswetter MD, MPH; Carrie Ceresa PharmD, MPH; Katie Haffenreffer BS; Marsha Reichman PhD

Data Sources
Mini-Sentinel Distributed Database (MSDD)
Related Assessments